UCHL5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.33066907387547E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.36077865326479E-14 |
Normal-vs-Stage2 |
4.152200E-04 |
Normal-vs-Stage3 |
4.44089209850063E-16 |
Normal-vs-Stage4 |
1.62636570877339E-12 |
Stage1-vs-Stage2 |
3.351000E-01 |
Stage1-vs-Stage3 |
5.736400E-03 |
Stage1-vs-Stage4 |
1.022220E-02 |
Stage2-vs-Stage3 |
2.154200E-02 |
Stage2-vs-Stage4 |
2.088200E-02 |
Stage3-vs-Stage4 |
9.370600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.63025148935958E-12 |
Normal-vs-AfricanAmerican |
1.63002944475465E-12 |
Normal-vs-Asian |
4.514200E-02 |
Caucasian-vs-AfricanAmerican |
1.387980E-02 |
Caucasian-vs-Asian |
3.492000E-01 |
AfricanAmerican-vs-Asian |
4.045600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
7.04180047605973E-11 |
Male-vs-Female |
6.259500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.86500000001855E-06 |
Normal-vs-Age(41-60Yrs) |
1.98896454861597E-12 |
Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(81-100Yrs) |
7.60389999965305E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.631000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.513200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.171600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.565200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.990400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.896600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.364400E-03 |
Normal-vs-Grade 2 |
6.46149800331841E-11 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.6269208202857E-12 |
Grade 1-vs-Grade 2 |
7.370600E-01 |
Grade 1-vs-Grade 3 |
1.330450E-01 |
Grade 1-vs-Grade 4 |
4.439900E-02 |
Grade 2-vs-Grade 3 |
6.998700E-03 |
Grade 2-vs-Grade 4 |
1.761580E-03 |
Grade 3-vs-Grade 4 |
1.136150E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.20319999996621E-06 |
Normal-vs-ccB subtype |
1.62436730732907E-12 |
ccA subtype-vs-ccB subtype |
2.855999999829E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.93700611106351E-12 |
Normal-vs-N1 |
1.637560E-02 |
N0-vs-N1 |
6.302400E-01 |
|
|